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Abstract
Background: The analysis of hemodialysis services is relevant for the quality of life of patient. In this study we
investigated the profile of vascular access used for hemodialysis patients in our Unit.
Methods: We evaluated 219 patients of both genders aged over 18 years old who have undergone implant
or manufacture of vascular hemodialysis access. We excluded patients on renal replacement therapy by
peritoneal dialysis.
Results: Associated diseases were hypertension and diabetes mellitus. 161 had arteriovenous fistula, with 153 held
by the same dialysis and nine of them were still maturing. 27 patients on dialysis used central venous catheter. 148
were indigenous and five were made using polytetrafluoroethylene prosthesis (PTFE). Among the 27 patients with
central venous catheters, ten used short-term catheter and 17 used long-term catheter. The most frequent type of
fistula use was on the radio distal cephalic, in 85 patients (52.5%), followed by radio cephalic proximal in 26
patients (16%). The number of fistulas in dialysis patients conducted by this kind of therapy ranged from one to
ten and in 64 patients (41.83%) fistula was the first and only to be made. Among the fistula for dialysis patients,
the highest prevalence was radio cephalic fistula in 111 patients (72.5%) and mean duration of use was 48.1
months, ranging from two months to 17 years.
Conclusion: Our Unit of hemodialysis is above the limits established by international norms.
Background
The need for a vascular access is as old as hemodialysis
and its adequate functioning is essential for effective
maintenance dialysis [1-5]. The ideal access allows a safe
approach, provides sufficient flow to perform hemodialy-
sis and has a low complication rate [1,6,7]. Among the
main access, through native fistula, fistula with prosthesis
and central venous catheters, a native fistula comes
closest to these premises [1,5-7]. Guidelines from differ-
ent countries recommend its use [2,6-9] and studies
showed that the native access presents the best patency
(4 to 5 years) and lower rate of reoperation when
compared with other accesses [6,7].
Catheters are associated with high rates of infection and
may compromise the subsequent manufacture of fistulas
[10,11]. Complications of vascular access are the main
causes of morbidity in chronic renal dialysis patients and
contribute to a high percentage of hospitalizations, result-
ing in high treatment costs [1,6,7,12]. As a consequence,
in recent years it has been emerging worldwide consen-
suses that aim to standardize the use of access in order to
reduce complications and to promote greater longevity of
the fistula and improve the patient’s quality of life [2].
The NKF-DOQI (National Kidney Foundation - Dialy-
sis Outcomes Quality Initiative) - Clinical Practice
Guidelines for Vascular Access, published in 1997 and
its updates, is an American consensus that establishes
guidelines and strategies for their implementation
in order to increase the rate of preparation of native
fistulas, aiming patient identification which is evolving
with kidney failure and protection of local fistulas
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must implement a program to detect accesses at risk,
complication rates and implement procedures to maxi-
mize accesses longevity [1,6,7].
Therefore, the analysis of frequent dialysis services is
essential for its adequacy in relation to recommended
guidelines and also to improvements of vascular access
with reduced morbidity and improved quality of life of
dialysis patients [1,2]. This context prompted us to
conduct this research, aiming to monitor the quality of
service and maintain control over the goals advocated
by these institutions. Thus, this study was undertaken to
evaluate the profile of vascular access used for hemodia-
lysis in patients from our Unit.
Method
Population
This is a descriptive transversal observational study
conducted on April to May 2008. We performed the
study on the dialysis unit in the Department of Nephrol-
o g yo ft h eF a c u l d a d ed eM e d i c i n ad oA B C ,i nt h eP a d r e
Anchieta Teaching Hospital and in the Mario Covas
Hospital. The sample consisted of 219 patients
(103 males). The study was approved by the Ethics Com-
mittee of the Faculty of Medicine of ABC, with question-
naires and physical examination in all patients on dialysis.
All patients gave informed consent. All procedures were
in compliance with the Helsinki Declaration.
Inclusion and exclusion criteria
We included patients of both genders aged over 18 years
old, which were in agreement with the consent term,
who have undergone implant or manufacture of vascular
hemodialysis access. We excluded patients on renal
replacement therapy by peritoneal dialysis.
Variables
We evaluated the following variables: gender, age, time
which the subject was using hemodyalisis, comorbidity,
actual and previous access and access complication.
Statistical Analysis
For the descriptive statistics we used the Microsoft
Excel
® program.
Results
We investigated a total of 180 patients, 99 (55%) from
Padre Anchieta Hospital and 81 (45%) from the Mário
Covas Hospital. Regarding gender, 98 patients were
males and 82 females. The average age was 52.32 years
old, ranging from 18 to 92 years old. The most common
etiology was renal hypertension, which was found in
40.5% of patients. Associated diseases were hypertension
and diabetes mellitus (Table 1).
Among the patients, 161 had arteriovenous fistula,
with 153 held by the same dialysis and nine of them
were still maturing. 27 patients on dialysis used central
venous catheter (Table 2). Among the 153 patients who
underwent hemodialysis through arteriovenous fistula,
148 were indigenous and five were made using polyte-
trafluoroethylene prosthesis (PTFE) (Table 2). Among
the 27 patients with central venous catheters, ten used
short-term catheter and 17 used long-term catheter
(Table 2).
Considering the patients with short-term catheter and
without maturing fistula (six patients), the average time
of using was 32.3 days (minimum of seven days and up
to 60 days). Patients on dialysis for long-term catheter
and without maturing fistula (12 patients) had a mean
time of 5.46 months of use and had already exhausted
their chances of making fistulas. The most frequent type
of fistula use was on the radio distal cephalic, in 85
patients (52.5%), followed by radio cephalic proximal in
26 patients (16%) (Table 3).
The number of fistulas in dialysis patients conducted
by this kind of therapy ranged from one to ten and in
64 patients (41.83%) fistula was the first and only to be
made. Among the fistula for dialysis patients, the highest
prevalence was radio cephalic fistula in 111 patients
(72.5%) and mean duration of use was 48.1 months,
ranging from two months to 17 years. These patients had
an average of 0.89 prior fistulas, and in 46 patients (30%)
it was the only fistula. Among the most frequent compli-
cations observed in fistulas in use, the pseudo-aneurysm
Table 1 Distribution of patients according to associated
diseases.
Associated diseases Number of patients %
Hypertension 154 86
Diabetes mellitus 53 30
Neoplasia 00
Coronary failure 01 0.5
Systemic Lupus Erythematosus 05 2.8
Others 06 3.2
Table 2 Distribution of vascular accesses in use.
Type of vascular access Number %
Arteriovenous fistula Native 148 82.2
PTFE 05 2.8
Catheter Short-term* 10 5.5
Long-term** 17 9.4
Total 180 100
%: percentage.
* Five patients with maturing fistula.
** One patient with maturing fistula.
PTFE: polytetrafluoroethylene.
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Discussion
It was created in 1997, the NKF-DOQI, establishing
guidelines for standardization of care for chronic kidney
illness to dialysis in relation to vascular access in order
to decrease the complications and cost, improve the
dialysis quality, thus, improving the patients quality of
life, since it was reported high number of use and
complications of vascular access for hemodialysis due to
catheter use and fistula with prosthesis [13]. The peri-
odic review of access for hemodialysis is intended to be
performed on all services in order to monitor their ade-
quacy in relation to international guidelines. According
to these premises, we performed at the Unit of Nephrol-
ogy from our University an investigation which aims to
verify the adequacy and monitor the vascular access,
within the standards established by the guidelines
(NKF-DOQI 2006).
The number of catheters reported in our study is in
accordance with the recommended by the NKF-DOQI
and a large proportion of patients with short-term
catheters presented fistulas in maturation. Making fistu-
las in patients before dialysis is a target in our service, it
is difficult because our patients are often at the end-
stage of renal disease. Patients with long-term catheters
are at the stage of exhaustion of vascular accesses and
some of them had fistulas at maturity which is also in
agreement with the guidelines.
In a recent investigation published by our group,
which evaluated saphenofemoral fistula as vascular
access for hemodialysis [3], it was observed some cases
of thrombosis due to prolonged arterial hypotension and
one case due to trauma of the fistula site at home envir-
onment. By studying this type of complication, we alert
to the importance of maintaining regular surveillance
with periodic evaluation of these fistulas in order to
detect early dysfunction so that it may be corrected in
time, reducing the risk of thrombosis and increasing the
usefulness period of the fistula [14].
According to our findings the percentage of patients
under dialysis with arteriovenous fistulas was higher
than the recommended by the NKF-DOQI 2006 (70%).
Furthermore, the location of fistulas is in accordance
with the guidelines. We reported predominance of distal
radio-cephalic, which has a high rate in the primary fis-
tulas, which is the ideal combination for the patient
because it is related to a lower complication rate and,
hence, improved quality of life [6,7].
Some issues should be addressed when taking vascular
access for hemodialysis. According to a recent study, the
limitation of saphenofemoral arteriovenous fistula as
hemodialysis access is given in cases when the patient
presents saphenous vein absence or when the saphenous
vein is inadequate for this purpose and also in patients
with arterial occlusive disease in the femoropopliteal
territory. Another limitation of this technique is that the
s a p h e n o u sv e i np r e v e n t st h ed e v e l o p m e n to ft h ef i s t u l a
due to its developed muscle layer, similar to the cephalic
vein in the internal forearm arteriovenous fistula.
Although it prevents aneurysmal dilatation it increases
the risk of myointimal hyperplasia after repeated
punctures of the arteriovenous fistula [15]. On the other
hand, because it is autologous material, it presents low
cost, higher infection resistance and it is easy to hand-
ling, the advantages compensate its limitations even
when compared to other access techniques in lower
limbs which also uses autologous material such as trans-
position of the superficial femoral vein, first described
by Huber et al [16], which reported two cases of use of
this vein, one in the thigh and one in the arm and also
reported by Gradman et al [17], in a retrospective study
of 25 cases, which used this technique in lower limbs.
This technique, which is an exception procedure,
showed very good results in its long-term use according
to our findings.
In addition, other complications such as distal ische-
mia, venous hypertension, cardiac decompensation,
anastomotic pseudoaneurysm, aneurysmal dilatation
and infection may be observed. For instance, Taylor et
al [18] performed 45 grafts ("in loop” and “in thigh”),
in whom polytetrafluoroethylene prosthesis were used
in 39 cases and bovine carotid artery in six cases.
They observed high rate of non-thrombotic complica-
tions with 18% of infection and 16% of distal limb
ischemia.
Our findings are of great relevance because the com-
plications with vascular access, especially catheters, are
major causes of morbidity and mortality in dialysis
patients [1,6,7,12]. Therefore, our findings fit with the
guidelines recommendation [6,7], which is important
for improving quality of life of patients with renal
dialysis.
Table 3 Distribution of fistulas according to location.
Type of fistula Number %
Distal radio cephalic 85 52.5
Proximal radio cephalic 26 16
Brachial cephalic 25 15
Brachial basilic 12 7.5
PTFE upper limb 04 2.5
Sapheno-femoral 01 0.6
Total 149 100
PTFE: polytetrafluoroethylene.
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The Unit of hemodialysis from our University is above
the limits established by international norms, as evi-
denced by the analysis phase of the study.
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